AIM at Melanoma - Reshaping the Future Together

In Memoriam

It is with profound sadness that we announce the death of AIM at Melanoma’s Founder & President, Valerie Guild

Skin Cancer Education & Research Foundation Launches New Website

A New Resource for the Fight Against Skin Cancer

May is Melanoma Awareness Month

Take the Pledge To Wear Sunscreen Every Time You Step Outside

Take The Pledge

COVID-19 UPDATE

An Update To Our Community

Peer Support For The Melanoma Community

It may bring some comfort to know that many others have traveled the same path as you

Research

Groundbreaking

Research

Research

Education & Support

Stages of Melanoma

Stage 0 (in situ)

Research

Reshaping the Future Together

Fundraising

AIM Walks & Fun Runs

AIM Fundraisers & Partner Programs

Questions About Melanoma?

Providing accurate answers to a wide range of melanoma questions on a confidential basis

I Have a Question

or call 877-246-2635

Search for a Melanoma Specialist

Clinical Trials Matching Service

Melanoma Education

From risk factors, to melanoma stages, to treatment, and beyond

Innovative Research

Changing the face and future of melanoma research to discover the cure

Global Engagement & Advocacy

Most influential voice in melanoma, locally and globally

Leading the Way in Legislation

Leading and winning legislative and regulatory change across the country

Melanoma News & Events

News 06/01/2020

Adjuvant pembrolizumab confers durable RFS benefit in resected stage III melanoma

News 06/01/2020

Encorafenib/Binimetinib Combo Continues to Show Survival Benefits in BRAF V600-Mutant Melanoma

News 05/29/2020

Novartis announces long-term, relapse-free survival benefit for high-risk, stage III melanoma patients treated with Tafinlar® + Mekinist® following surgery

News 04/28/2020

FDA Approves Additional Recommended Dose of Pembrolizumab in Adults

News 04/28/2020

Roche's triple threat—Tecentriq, Cotellic and Zelboraf—stalls melanoma progression

News 04/28/2020

Merck pads case for less-frequent Keytruda dosing with new melanoma data

News 04/28/2020

Triplet Succeeds in BRAF-Mutant Melanoma

News 02/27/2020

AIM At Melanoma And The Mollie Biggane Melanoma Foundation Offer New Education Brochure

News 01/23/2020

Seven sunscreen chemicals enter bloodstream after one use, FDA says, but don't abandon sun protection

News 12/13/2019

Roche’s Tecentriq cocktail scores trial success in melanoma

News 12/10/2019

Association of Community Cancer Centers Project Focuses on Multidisciplinary Cutaneous Squamous Cell Carcinoma Care

News 11/21/2019

Opdivo/Yervoy combo for melanoma fails in key patient population

News 11/15/2019

Nivolumab Combined with Ipilimumab or Alone Outperforms Ipilimumab at 5 Years in Advanced Melanoma

News 11/15/2019

Cases of Melanoma are Falling Among Young People in the United States

News 09/28/2019

Nivolumab Combined with Ipilimumab or Alone Outperforms Ipilimumab at 5 Years in Advanced Melanoma

Please keep me informed.

Receive comprehensive, breaking news about melanoma, research, legislation, and events.

First Name*
Last Name*
Email*
Address*
State / Province / Region ZIP / Postal Code Country
Email
This field is for validation purposes and should be left unchanged.